Review
Sep 2026
Pancreatic ductal adenocarcinoma: Clinical trials to watch.
The treatment of PDAC is transitioning from uniform cytotoxic chemotherapy toward precision strategies guided by molecular identity and disease stage. RAS and PARP inhibitors and personalized neoantigen vaccination have created new options across metastatic and resectable disease. Chemotherapy timing relative to surger...
V. P. Groot, I. Molenaar, G. Cirkel et al.
· i Medicina · 0 citations